Envestnet Asset Management
BBP icon

Envestnet Asset Management’s Virtus Biotech ETF BBP Stock Holding History

Envestnet Asset Management’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
18,235
+734
+4% +$63.9K ﹤0.01% 3247
2026
Q1 		$1.45M Buy
+17,501
New +$1.44M ﹤0.01% 3231

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Envestnet Asset Management's BBP Position: Q2 2026 in Review

Envestnet Asset Management increased its Virtus Biotech ETF (BBP) stake by 4.2% in Q2 2026, buying an estimated $63.9K and bringing the position to 18,235 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

Envestnet Asset Management first reported a position in BBP in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Envestnet Asset Management held 18,235 shares of Virtus Biotech ETF worth $1.76M as of Q2 2026.
  • Envestnet Asset Management bought 734 Virtus Biotech ETF shares in Q2 2026, an estimated $63.9K.
  • Virtus Biotech ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3247 holding.
  • Envestnet Asset Management first reported a position in Virtus Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.